Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology

Does DM1 Cause Apathy and Personality Changes?

At a Glance

Yes, myotonic dystrophy type 1 (DM1) frequently causes apathy, executive dysfunction, and perceived personality changes. These are neurological symptoms caused by physical changes in the brain, not a lack of effort or laziness. Managing these symptoms requires external cues and caregiver support.

Apathy, executive dysfunction, and perceived personality changes are very common, core symptoms of myotonic dystrophy type 1 (DM1). For many patients and their caregivers, it can feel like motivation has entirely disappeared. However, this profound lack of drive is not laziness, a personal flaw, or simply feeling sad. Instead, apathy is a neurological symptom of DM1, caused by physical changes in how the brain functions [1][2]. Understanding that these behavioral changes are biological features of the disease is a crucial step for both patients and their families to reduce guilt and frustration.

How DM1 Affects the Brain

While DM1 is primarily known for its impact on muscles, it is actually a multisystem disorder that heavily impacts the central nervous system (the brain and spinal cord) [1]. The genetic mutation that causes DM1 leads to physical changes in the brain over time [3]. This includes alterations in the brain’s white matter (the “cables” that connect different brain regions) and iron accumulation in deep brain structures [4][1].

Because of these structural changes, patients frequently develop executive dysfunction—difficulty with planning, organizing, making decisions, and initiating tasks [5][6]. Symptoms can vary from person to person depending on the severity of the disease and how long you have lived with it [3][1].

Apathy vs. Depression

It is vital to distinguish between apathy and depression. While a person with DM1 can certainly experience depression, apathy is a distinct, highly common symptom of the disease [7].

  • Apathy is a severe loss of motivation, initiative, and emotional responsiveness. You may seem indifferent to things you used to love or lack the drive to start conversations or activities, but you do not necessarily feel profound sadness [1].
  • Depression typically involves feelings of deep sadness, worthlessness, or hopelessness [7].

In DM1, researchers believe that structural brain changes and potential abnormalities in the brain’s dopamine system (which controls reward and motivation) play a direct role in this profound apathy and difficulty making decisions [1][6].

The Role of the “Myopathic Face”

The perception of apathy is often magnified by myopathic facies, a medical term for facial muscle weakness [8]. As the muscles in the face weaken, a person with DM1 may lose their ability to make normal facial expressions, such as smiling, frowning, or showing surprise [2][8].

When you have a blank or “flat” facial expression, loved ones naturally interpret this as a lack of interest or emotion. When this physical inability to show emotion on the face is combined with genuine neurological apathy, it can severely impact communication and create massive strain in relationships [1][9]. It is incredibly helpful for families to remember that your outward expression may not reflect what you are actually feeling inside.

Managing the Symptoms

Living with severe apathy and executive dysfunction is exhausting for the patient and can feel deeply isolating for the caregiver. Because these symptoms are part of the disease, and not a choice, specific strategies are needed to manage them.

Strategies for Patients

  • Use external cues: Because internal motivation is affected by the disease, rely on external tools. Use phone alarms, digital calendars, or checklists to prompt you to start tasks.
  • Ask for a “jumpstart”: Because of executive dysfunction, you might struggle to initiate a task but can follow through once started. Ask a loved one to help you begin an activity.
  • Talk to your doctor about sleep: Fatigue and excessive daytime sleepiness drain your motivation [2][10]. Your neurologist may be able to prescribe wakefulness-promoting medications to help improve your daytime energy.

Strategies for Loved Ones

  • Simplify requests: Break complex activities into small, concrete steps. A broad request like “clean the kitchen” might trigger executive dysfunction and be overwhelming, whereas “please load the plates into the dishwasher” is manageable and clear [5].
  • Separate the person from the disease: Recognize that apathy is a biological, neurological symptom, not a conscious choice to withdraw. This shift in perspective can help reduce feelings of resentment.
  • Seek multidisciplinary support: Working with a care team that includes neuropsychologists or behavioral therapists is highly recommended to help navigate these relationship changes and provide coping mechanisms for the whole family [3][11].

Common questions in this guide

Is apathy in myotonic dystrophy different from depression?
Yes, apathy and depression are distinct in DM1. Apathy is a severe loss of motivation and drive caused by structural brain changes, while you do not necessarily feel profound sadness. Depression typically involves deep feelings of sadness, worthlessness, or hopelessness.
Why does myotonic dystrophy cause a lack of motivation?
The genetic mutation in DM1 causes physical changes in the central nervous system, including alterations to white matter and dopamine pathways. These neurological changes directly lead to executive dysfunction and profound apathy, making it difficult to plan or initiate tasks.
What is a myopathic face in myotonic dystrophy?
A myopathic face refers to facial muscle weakness that limits a person's ability to make normal facial expressions, such as smiling or frowning. This physical inability to show emotion outwardly can make a person appear apathetic or indifferent to others, even if they feel differently inside.
How can caregivers help someone with myotonic dystrophy who has severe apathy?
Loved ones can help by breaking complex requests into small, concrete steps to avoid triggering executive dysfunction. Helping to initiate or 'jumpstart' a task is also highly effective, as patients often struggle to start an activity but can follow through once it begins.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are there medications, such as wakefulness-promoting agents, available to help manage my excessive daytime sleepiness and improve my energy levels?
  2. 2.How can we tell the difference between my DM1-related apathy and clinical depression?
  3. 3.Can you refer me to a neuropsychologist or occupational therapist who has experience with the cognitive and executive function changes in myotonic dystrophy?
  4. 4.Could poor sleep quality, such as sleep apnea or nighttime breathing issues, be making my apathy and fatigue worse?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

    Miller JN, Kruger A, Moser DJ, et al.

    Frontiers in neurology 2021; (12()):700796 doi:10.3389/fneur.2021.700796.

    PMID: 34276551
  2. 2

    Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.

    Van Heugten C, Meuleman S, Hellebrekers D, et al.

    Journal of neuromuscular diseases 2018; (5(2)):205-214 doi:10.3233/JND-170246.

    PMID: 29865086
  3. 3

    Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

    Callus E, Bertoldo EG, Beretta M, et al.

    Frontiers in neurology 2018; (9()):751 doi:10.3389/fneur.2018.00751.

    PMID: 30298045
  4. 4

    Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla.

    Ates S, Deistung A, Schneider R, et al.

    Frontiers in neurology 2019; (10()):1320 doi:10.3389/fneur.2019.01320.

    PMID: 31920940
  5. 5

    Myotonic Dystrophy Type 1 (DM1): Clinical Characteristics and Disease Progression in a Large Cohort.

    Chawla T, Reddy N, Jankar R, et al.

    Neurology India 2024; (72(1)):83-89 doi:10.4103/neuroindia.NI_1432_20.

    PMID: 38443007
  6. 6

    Ventral tegmental area dysfunction affects decision-making in patients with myotonic dystrophy type-1.

    Serra L, Scocchia M, Meola G, et al.

    Cortex; a journal devoted to the study of the nervous system and behavior 2020; (128()):192-202 doi:10.1016/j.cortex.2020.03.022.

    PMID: 32361267
  7. 7

    A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

    Minier L, Lignier B, Bouvet C, et al.

    Journal of neuromuscular diseases 2018; (5(3)):279-294 doi:10.3233/JND-180310.

    PMID: 30040740
  8. 8

    Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.

    Sharp L, Cox DC, Cooper TA

    Muscle & nerve 2019; (60(6)):779-789 doi:10.1002/mus.26709.

    PMID: 31509256
  9. 9

    Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.

    Okkersen K, Jimenez-Moreno C, Wenninger S, et al.

    The Lancet. Neurology 2018; (17(8)):671-680 doi:10.1016/S1474-4422(18)30203-5.

    PMID: 29934199
  10. 10

    Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy.

    Johnson NE, Ekstrom AB, Campbell C, et al.

    Developmental medicine and child neurology 2016; (58(7)):698-705 doi:10.1111/dmcn.12948.

    PMID: 26510705
  11. 11

    Having an eye for myotonic dystrophy: A qualitative study on experiences and support needs in myotonic dystrophy type 1 patients with a diagnostic delay after early-onset cataract.

    Karnebeek IEA, Boon HTM, Huis AMP, et al.

    Neuromuscular disorders : NMD 2022; (32(10)):829-835 doi:10.1016/j.nmd.2022.09.003.

    PMID: 36192279

This page explains the behavioral and cognitive symptoms of myotonic dystrophy for educational purposes only. Always consult your neurologist or care team for proper diagnosis and management strategies.

Get notified when new evidence is published on Myotonic dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.